We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Long-Awaited Report Blasts FDA, Calls for Increased Postmarket Authority
Long-Awaited Report Blasts FDA, Calls for Increased Postmarket Authority
October 16, 2006
The U.S. Food and Drug Administration (FDA) should be given the authority to impose severe punishments on drug manufacturers who dont live up to their postmarketing commitments, according to an Institute of Medicine (IOM) report that offers a harsh assessment of the agencys current drug safety efforts.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor